Literature DB >> 24397476

Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.

Hebist Berhane1, Michael W Epperly, Julie Goff, Ronny Kalash, Shaonan Cao, Darcy Franicola, Xichen Zhang, Donna Shields, Frank Houghton, Hong Wang, Peter Wipf, Kalindi Parmar, Joel S Greenberger.   

Abstract

FancD2 plays a central role in the human Fanconi anemia DNA damage response (DDR) pathway. Fancd2(-/-) mice exhibit many features of human Fanconi anemia including cellular DNA repair defects. Whether the DNA repair defect in Fancd2(-/-) mice results in radiologic changes in all cell lineages is unknown. We measured stress of hematopoiesis in long-term marrow cultures and radiosensitivity in clonogenic survival curves, as well as comet tail intensity, total antioxidant stores and radiation-induced gene expression in hematopoietic progenitor compared to bone marrow stromal cell lines. We further evaluated radioprotection by a mitochondrial-targeted antioxidant GS-nitroxide, JP4-039. Hematopoiesis longevity in Fancd2(-/-) mouse long-term marrow cultures was diminished and bone marrow stromal cell lines were radiosensitive compared to Fancd2(+/+) stromal cells (Fancd2(-/-) D0 = 1.4 ± 0.1 Gy, ñ = 5.0 ± 0.6 vs. Fancd2(+/+) D0 = 1.6 ± 0.1 Gy, ñ = 6.7 ± 1.6), P = 0.0124 for D0 and P = 0.0023 for ñ, respectively). In contrast, Fancd2(-/-) IL-3-dependent hematopoietic progenitor cells were radioresistant (D0 = 1.71 ± 0.04 Gy and ñ = 5.07 ± 0.52) compared to Fancd2(+/+) (D0 = 1.39 ± 0.09 Gy and ñ = 2.31 ± 0.85, P = 0.001 for D0). CFU-GM from freshly explanted Fancd2(-/-) marrow was also radioresistant. Consistent with radiosensitivity, irradiated Fancd2(-/-) stromal cells had higher DNA damage by comet tail intensity assay compared to Fancd2(+/+) cells (P < 0.0001), slower DNA damage recovery, lower baseline total antioxidant capacity, enhanced radiation-induced depletion of antioxidants, and increased CDKN1A-p21 gene transcripts and protein. Consistent with radioresistance, Fancd2(-/-) IL-3-dependent hematopoietic cells had higher baseline and post irradiation total antioxidant capacity. While, there was no detectable alteration of radiation-induced cell cycle arrest with Fancd2(-/-) stromal cells, hematopoietic progenitor cells showed reduced G2/M cell cycle arrest. The absence of the mouse Fancd2 gene product confers radiosensitivity to bone marrow stromal but not hematopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24397476      PMCID: PMC3970166          DOI: 10.1667/RR13405.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  27 in total

1.  GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.

Authors:  Mark E Bernard; Hyun Kim; Hebist Berhane; Michael W Epperly; Darcy Franicola; Xichen Zhang; Frank Houghton; Donna Shields; Hong Wang; Christopher J Bakkenist; Marie-Celine Frantz; Erin M Forbeck; Julie P Goff; Peter Wipf; Joel S Greenberger
Journal:  Radiat Res       Date:  2011-09-22       Impact factor: 2.841

2.  Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1.

Authors:  Kalindi Parmar; Jungmin Kim; Stephen M Sykes; Akiko Shimamura; Patricia Stuckert; Kaya Zhu; Abigail Hamilton; Mary Kathryn Deloach; Jeffery L Kutok; Koichi Akashi; D Gary Gilliland; Alan D'andrea
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

3.  Intraesophageal manganese superoxide dismutase-plasmid liposomes ameliorates novel total-body and thoracic radiation sensitivity of NOS1-/- mice.

Authors:  Malolan S Rajagopalan; Brandon Stone; Jean-Claude Rwigema; Umar Salimi; Michael W Epperly; Julie Goff; Darcy Franicola; Tracy Dixon; Shaonan Cao; Xichen Zhang; Bettina M Buchholz; Anthony J Bauer; Serah Choi; Christopher Bakkenist; Hong Wang; Joel S Greenberger
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

4.  Two strategies for the development of mitochondrion-targeted small molecule radiation damage mitigators.

Authors:  Jean-Claude M Rwigema; Barbara Beck; Wei Wang; Alexander Doemling; Michael W Epperly; Donna Shields; Julie P Goff; Darcy Franicola; Tracy Dixon; Marie-Céline Frantz; Peter Wipf; Yulia Tyurina; Valerian E Kagan; Hong Wang; Joel S Greenberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-13       Impact factor: 7.038

Review 5.  Molecular biology of Fanconi anemia: implications for diagnosis and therapy.

Authors:  A D D'Andrea; M Grompe
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

6.  Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining.

Authors:  Scott Houghtaling; Amy Newell; Yassmine Akkari; Toshiyasu Taniguchi; Susan Olson; Markus Grompe
Journal:  Hum Mol Genet       Date:  2005-08-31       Impact factor: 6.150

Review 7.  Fanconi's anemia and malignancies.

Authors:  B P Alter
Journal:  Am J Hematol       Date:  1996-10       Impact factor: 10.047

8.  p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia.

Authors:  F Rosselli; A Ridet; T Soussi; E Duchaud; C Alapetite; E Moustacchi
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

9.  Time-dose response of human tumors and normal tissues during and after fractionated radiation treatment. A new model.

Authors:  J van de Geijn
Journal:  Radiother Oncol       Date:  1988-05       Impact factor: 6.280

10.  Targeting the fanconi anemia pathway to identify tailored anticancer therapeutics.

Authors:  Chelsea Jenkins; Jenny Kan; Maureen E Hoatlin
Journal:  Anemia       Date:  2012-05-24
View more
  23 in total

1.  FANCD2 protects against bone marrow injury from ferroptosis.

Authors:  Xinxin Song; Yangchun Xie; Rui Kang; Wen Hou; Xiaofang Sun; Michael W Epperly; Joel S Greenberger; Daolin Tang
Journal:  Biochem Biophys Res Commun       Date:  2016-10-20       Impact factor: 3.575

2.  Anti-Ferroptosis Drug Enhances Total-Body Irradiation Mitigation by Drugs that Block Apoptosis and Necroptosis.

Authors:  Stephanie Thermozier; Wen Hou; Xichen Zhang; Donna Shields; Renee Fisher; Hulya Bayir; Valerian Kagan; Jian Yu; Bing Liu; Ivet Bahar; Michael W Epperly; Peter Wipf; Hong Wang; M Saiful Huq; Joel S Greenberger
Journal:  Radiat Res       Date:  2020-03-05       Impact factor: 2.841

3.  Radioresistance of Serpinb3a-/- Mice and Derived Hematopoietic and Marrow Stromal Cell Lines.

Authors:  Stephanie Thermozier; Xichen Zhang; Wen Hou; Renee Fisher; Michael W Epperly; Bing Liu; Ivet Bahar; Hong Wang; Joel S Greenberger
Journal:  Radiat Res       Date:  2019-07-11       Impact factor: 2.841

4.  Continuous One Year Oral Administration of the Radiation Mitigator, MMS350, after Total-Body Irradiation, Restores Bone Marrow Stromal Cell Proliferative Capacity and Reduces Senescence in Fanconi Anemia (Fanca-/-) Mice.

Authors:  Aranee Sivananthan; Donna Shields; Renee Fisher; Wen Hou; Xichen Zhang; Darcy Franicola; Michael W Epperly; Peter Wipf; Joel S Greenberger
Journal:  Radiat Res       Date:  2018-11-30       Impact factor: 2.841

5.  Intraoral Mitochondrial-Targeted GS-Nitroxide, JP4-039, Radioprotects Normal Tissue in Tumor-Bearing Radiosensitive Fancd2(-/-) (C57BL/6) Mice.

Authors:  Ashwin Shinde; Hebist Berhane; Byung Han Rhieu; Ronny Kalash; Karen Xu; Julie Goff; Michael W Epperly; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Kalindi Parmar; Eva Guinan; Valerian Kagan; Vladimir Tyurin; Robert L Ferris; Xiaolan Zhang; Song Li; Joel S Greenberger
Journal:  Radiat Res       Date:  2016-01-20       Impact factor: 2.841

6.  Induction of TGF-β by Irradiation or Chemotherapy in Fanconi Anemia (FA) Mouse Bone Marrow Is Modulated by Small Molecule Radiation Mitigators JP4-039 and MMS350.

Authors:  Michael W Epperly; Byung-Han Rhieu; Darcy Franicola; Tracy Dixon; Shaonan Cao; Xichen Zhang; Donna Shields; Hong Wang; Peter Wipf; Joel S Greenberger
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

7.  Inhibition of MEK confers hypersensitivity to X-radiation in the context of BRAF mutation in a model of childhood astrocytoma.

Authors:  Adam Studebaker; Kathryn Bondra; Star Seum; Changxian Shen; Doris A Phelps; Christopher Chronowski; Justin Leasure; Paul D Smith; Raushan T Kurmasheva; Xiaokui Mo; Maryam Fouladi; Peter J Houghton
Journal:  Pediatr Blood Cancer       Date:  2015-05-15       Impact factor: 3.167

8.  Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.

Authors:  Hebist Berhane; Ashwin Shinde; Ronny Kalash; Karen Xu; Michael W Epperly; Julie Goff; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Song Li; Xiang Gao; Joel S Greenberger
Journal:  Radiat Res       Date:  2014-06-16       Impact factor: 2.841

9.  Amelioration of Head and Neck Radiation-Induced Mucositis and Distant Marrow Suppression in Fanca-/- and Fancg-/- Mice by Intraoral Administration of GS-Nitroxide (JP4-039).

Authors:  John Willis; Michael W Epperly; Renee Fisher; Xichen Zhang; Donna Shields; Wen Hou; Hong Wang; Song Li; Peter Wipf; Kalindi Parmar; Eva Guinan; Justin Steinman; Joel S Greenberger
Journal:  Radiat Res       Date:  2018-03-27       Impact factor: 2.841

10.  Fanconi Anemia Mouse Genotype-specific Mitigation of Total Body Irradiation by GS-Nitroxide JP4-039.

Authors:  Michael W Epperly; Renee Fisher; Xichen Zhang; Wen Hou; Donna Shields; Peter Wipf; Hong Wang; Stephanie Thermozier; Joel S Greenberger
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.